Clinical Trials · NCT06627530
COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcer
- Phase
- Phase 4
- Recruitment status
- Active Not Recruiting
- Sponsor
- Brazilian Clinical Research Institute
- Enrollment
- 144
- Start date
- Feb 2025
- Locations
- 6 sites, Brazil
- Primary endpoint
- Proportion of patients with minimal residual disease